Diversified Healthcare Trust (DHC) Projected to Post Quarterly Earnings on Monday

Diversified Healthcare Trust (NASDAQ:DHC) is projected to issue its quarterly earnings data after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of ($0.29) per share and revenue of $370.97 million for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Diversified Healthcare Trust Stock Down 5.3 %

Shares of NASDAQ:DHC opened at $2.48 on Friday. The company has a market capitalization of $598.35 million, a price-to-earnings ratio of -1.54 and a beta of 2.17. Diversified Healthcare Trust has a 1 year low of $2.01 and a 1 year high of $4.24. The company has a debt-to-equity ratio of 1.44, a current ratio of 11.57 and a quick ratio of 11.57. The business’s 50-day moving average is $2.35 and its 200-day moving average is $2.92.

Diversified Healthcare Trust Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Monday, January 27th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date of this dividend was Monday, January 27th. Diversified Healthcare Trust’s payout ratio is -2.48%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a report on Wednesday, January 29th.

Diversified Healthcare Trust Company Profile

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.